Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Authors: John R Teerlink, G Michael Felker, John J V McMurray, Scott D Solomon, Kirkwood F Adams, John G F Cleland, Justin A Ezekowitz, Assen Goudev, Peter Macdonald, Marco Metra, Veselin Mitrovic, Piotr Ponikowski, Pranas Serpytis, Jindrich Spinar, János Tomcsányi, Hans J Vandekerckhove, Adriaan A Voors, Maria Laura Monsalvo, James Johnston, Fady I Malik, Narimon Honarpour
Institutions: San Francisco VA Medical Center, University of California, San Francisco, University of California San Francisco Medical Center, Duke University, Duke Medical Center, University of Glasgow, Brigham and Women's Hospital, Harvard University, University of North Carolina at Chapel Hill, Harefield Hospital, Imperial College London, University of Alberta, Queen Giovanna Hospital, Victor Chang Cardiac Research Institute, UNSW Sydney, University of Brescia, Goethe University Frankfurt, Kerckhoff Klinik, Wroclaw Medical University, Vilnius University Hospital Santariskiu Klinikos, Masaryk University, University Hospital Brno, Szent János Kórház, AZ Sint-Lucas, University Medical Center Groningen, University of Groningen, Amgen (United States), Cytokinetics (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2558812366